In 2018, DNDi’s treatment access team also worked with local health authorities to develop a workshop for doctors and nurses to improve their skills in reading electrocardiogram test results.
- The 2nd LEAP Scientific Conference has been postponed. The new dates will be announced once they are available.
DNDi is piloting a global SIM card service designed by The Foundation for Innovative New Diagnostics (FIND) to send clinical trial data securely from several clinical sites in the Democratic Republic of Congo (DRC). SIMs are small cards containing chips that are used in mobile phones and other connected devices to transmit data over the Internet in a secure manner.
SciTech Africa [13 February 2019]
“Why developing new drugs in Africa is an effective way to develop its pharmaceutical industry”
Meeting opened by Ugandan Prime Minister convenes public & private sector partners from more than 40 countries
On 4 October 2018, DNDi held its 11th Partners’ Meeting in Kampala, Uganda. The meeting gathered together more than 400 partners and stakeholders from over 150 institutions and more than 40 countries, primarily African.
In early October, 18 journalists from 11 African countries converged in Kampala, Uganda for DNDi’s first-ever training on health and science journalism. The three-day training was conducted during a week of workshops and meetings related to the work of DNDi and its many partners, culminating in the 11th DNDi Partners’ Meeting on 4 October 2018.
67th Annual Meeting
28 October – 1 November 2018
New Orleans, USA
- Nathalie Strub-Wourgaft, NTD Director – presentation on fexinidazole in a symposium on sleeping sickness elimination
- Colin Forsyth, Chagas Epidemiologist, Sergio Sosa Estani, Head of Chagas Clinical Programme, Eric Chatelain, Head of Drug Discovery Programme – symposium on screening and diagnosis of Chagas disease
- Poster and oral presentations on sleeping sickness, visceral leishmaniasis, Chagas, onchocerciasis, and mycetoma
Former DNDi Medical Director Dr Nathalie Strub-Wourgaft takes over leadership of NTD programme
DNDi is pleased to announce the appointment of Dr Nathalie Strub-Wourgaft as the new Director of Neglected Tropical Diseases. She will assume her new role as NTD Director and member of DNDi’s Executive Team as of 1 July 2018.
Jornal da USP [20 June 2018]
“Evento traz novas tecnologias aplicadas na descoberta de medicamentos” – “Event overviews new technologies used in drug discovery”
3-4 October 2018
- DNDi – sessions on the LEAP Platform activities, policy, the AfriKADIA project, PKDL, and capacity strengthening
Phase II/III study results confirmed that fexinidazole, DNDi’s first new chemical entity is safe and effective, and presents significant advantages over current treatment as it removes the need for lumbar puncture and systematic patient hospitalization. A regulatory dossier has been submitted to the European Medicines Agency for fexinidazole as the first all-oral treatment for sleeping sickness.
Scroll.in [27 November, 2017]
“India will miss its deadline to eliminate kala azar by the end of December”
Futurism [19 October, 2017]
“Scientists cured a deadly neurological disease using a revolutionary method”
Nature [18 October, 2017]
“Sleeping sickness can now be cured with pills”
Health Analytics India [17 October, 2017]
“How India can help eliminate neglected diseases”
Radis [1 October, 2017]
“Pessoas negligenciadas, políticas globais” – “Neglected people, global policies”
Combining patient data from visceral leishmaniasis clinical trials would give scientists and clinicians more tools to understand and treat the disease which can be fatal if untreated.